PPADS: an antagonist at endothelial P2Y-purinoceptors but not P2U-purinoceptors

British Journal of Pharmacology
C A BrownM R Boarder

Abstract

1. Bovine aortic endothelial (BAE) cells contain two co-existing receptors for extracellular ATP, the P2Y and P2U-purinoceptors. Here we have determined whether the proposed P2X-purinoceptor antagonist, pyridoxalphosphate-6-azophenyl-2', 4'-disulphonic acid (PPADS) could distinguish between these two receptor subtypes. 2. Cells labelled with myo-[2-3H]-inositol were stimulated with increasing concentrations of either the P2Y-agonist, 2MeSATP, or the P2U-agonist, UTP in the absence or presence of 30 microM PPADS. The accumulation of total [3H]-inositol (poly)phosphates mediated by 2MeSATP was markedly attenuated by PPADS, whereas the response to UTP was not significantly affected. 3. Stimulation of BAE cells with increasing concentrations of ATP showed a reduced response in the presence of 10 microM PPADS, but this effect of the antagonist was not significant. By contrast, inhibition of the response to ADP was profound and highly significant. 4. These observations show that PPADS is not a selective P2X-purinoceptor antagonist, but is able to distinguish between P2Y- and P2YU-purinoceptors in BAE cells, and indicate that this compound may provide a useful tool in the study of multiple subtypes of P2-purinoceptors. Furthermore the...Continue Reading

References

Jul 7, 1992·European Journal of Pharmacology·G LambrechtE Mutschler
Feb 1, 1988·British Journal of Pharmacology·P M Dunn, A G Blakeley
Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·K D LustigD Julius
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·C E ParrJ T Turner
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·C E ParrJ T Turner
Sep 1, 1993·The American Journal of Physiology·G R Dubyak, C el-Moatassim
Dec 1, 1993·British Journal of Pharmacology·A U ZiganshinG Burnstock

❮ Previous
Next ❯

Citations

Jun 13, 1996·European Journal of Pharmacology·M Eltze, B Ullrich
Dec 19, 1996·European Journal of Pharmacology·D CommuniS Pirotton
Aug 11, 1998·European Journal of Pharmacology·G J McLarenC Kennedy
Nov 19, 1997·Neuropharmacology·J B SchachterT K Harden
Apr 30, 1999·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·M SugiokaM Yamashita
Apr 1, 1997·British Journal of Pharmacology·C E Gargett, J S Wiley
Aug 1, 1997·British Journal of Pharmacology·B F KingG Burnstock
Oct 24, 1998·British Journal of Pharmacology·A R ConantA W Simpson
Dec 1, 1999·British Journal of Pharmacology·D CommuniJ M Boeynaems
Jan 30, 2002·British Journal of Pharmacology·Robert A Kaiser, Iain L O Buxton
Jan 22, 1998·Journal of Cardiovascular Pharmacology·H ZhangR L Macdonald
Dec 1, 1996·Journal of Autonomic Pharmacology·G Lambrecht
Jun 1, 1996·British Journal of Pharmacology·S J CharltonM R Boarder
Oct 1, 1996·The Journal of Pharmacy and Pharmacology·U Windscheif
Dec 20, 2005·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Airat U ZiganshinGeoffrey Burnstock
Feb 25, 2005·Journal of Leukocyte Biology·Matt J SylteCharles J Czuprynski
Oct 11, 2003·American Journal of Physiology. Heart and Circulatory Physiology·John B BuckwalterPhilip S Clifford
Aug 1, 2001·Drug Development Research·Sean G BrownBrian F King
Oct 18, 2000·Journal of Neurochemistry·A I JiménezM T Miras-Portugal
Aug 13, 1999·The American Journal of Physiology·P B AnningM J Lewis
Oct 5, 2001·Journal of Cardiovascular Pharmacology and Therapeutics·M K ShahP J Kadowitz
Mar 6, 1999·Biochemical and Biophysical Research Communications·P VigneC Frelin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.